2021 SUMMIT
Oct 25-27, 2021
Nashville, TN

AN ACTION-ORIENTED SUMMIT ON THE DATA AND DIGITAL INFRASTRUCTURE PRECISION MEDICINE NEEDS TO THRIVE

Stakeholders across the healthcare system face significant barriers to the effective implementation of precision medicine.

Solutions must carefully consider the practical realities of a complex, multi-stakeholder environment.

This Summit provides influential leaders a candid, collaborative forum to define and implement solutions that connect the genetic health information network.

An intimate meeting of influential leaders from across in the Genetic Health Information Network

Representing all stakeholders in this ecosystem, including
  • Health plans
  • Clinicians
  • Hospital systems
  • Researchers
  • Policy makers
  • Patients & Advocates
  • Laboratories
  • IT Vendors
  • Pharma

2021 Organizing Committee

PRISCILLA ALFARO, MD

Chief Medical Officer

Zelis

JIM ALMAS, MD

 VP & National Medical Director for Clinical Effectiveness

LabCorp

MARA ASPINALL

Managing Director and Co-Founder

BlueStone Venture Partners

DAWN BARRY

Co-Founder & President

LunaDNA

Carlos Bustamante, PhD

Founder & CEO

Galatea Bio

DEBRA ESSER, MD

Chief Medical Officer

Blue Cross and Blue Shield of Nebraska

PHILLIP FEBBO, MD

SVP & Chief Medical Officer

Illumina

STEVE GOLDBERG, MD

VP, Chief Health Officer, Medical Affairs & Diagnostic Services

Quest Diagnostics

Gillian Hooker, PhD, ScM, LCGC

Chief Scientific Officer

Concert Genetics

DAX KURBEGOV, MD

VP & Physician-in-Chief of Clinical Programs

Sarah Cannon Cancer Institute

HOWARD LEVY, MD, PHD

Associate Professor of Medicine

Johns Hopkins Medicine

ROBERT NUSSBAUM, MD

Chief Medical Officer

Invitae

RANDY SCOTT, PHD

CEO

Thinking Bench Capital

BEN SOLOMON, MD

Clinical Director, National Human Genome Research Institute

National Institutes of Health (NIH)

DAVE SOSNOW

VP, Product Management

American Medical Association (AMA)

ROBERT STEINER, MD

Clinical Professor

Univ. of Wisconsin

Chief Medical Officer

PreventionGenetics

The only multi-stakeholder gathering focused on solving the data, digital infrastructure, and economic challenges facing precision medicine

Intimate, carefully curated, invitation-only gathering

Full spectrum of stakeholders

Focused on needs and solutions

Collaborative, discussion-oriented format

Chatham-house rules — non-attribution

No sponsored talks, sales pitches or marketing lists

Published conference summary and recommendations

Identify and resolve practical barriers facing precision medicine by

  • Improving the capture of clinical effectiveness and economic value data
  • Simplifying the test ordering and resulting workflow for clinicians, hospitals and labs
  • Streamlining the genetic test billing, adjudication and payment process
  • Reducing the frequency of misordered tests and surprise bills for patients
  • Empowering patients to harness the insights in their genetic makeup for greater health

2021 Speakers & Agenda

For the 2021 working agenda, click here.

Mara Aspinall

Managing Director and Co-Founder

BlueStone Venture Partners

Simon Barnett

Genomics Analyst

ARK Invest

Carlos Bustamante, PhD

Founder & CEO

Galatea Bio

Chip Chambers, MD

Founder & President

DADA2 Foundation

Andy Corts

SVP, Research & Analytics

Signal Path
(acq. by Verily, an Alphabet company)

Holli Dilks, PhD

Senior Director, Global Head of Field Medical

Foundation Medicine

Jeff Emch

Vice President, Diagnostics Strategy,
Global Oncology Marketing

GSK

Emily Evans

Managing Director

Hedgeye

Jill Hagenkord, MD

CMO

Optum Genomics

Edmund Jackson, PhD

Chief Data Officer

HCA Healthcare

Ben Ho Park, MD, PhD

Professor & Director, Division of Hematology and Oncology

Vanderbilt University Medical Center

Brad Smith

Founder & CEO, Russell Street Ventures

Former Director, CMMI &
Deputy Director, White House Domestic Policy Council

+78 Net Promoter Score

This Summit is back by popular demand thanks to the enthusiastic response of last year’s participants.

“Intimate engagement with key stakeholders in the genomic medicine space that does not otherwise happen all that often…Excellent and efficient organization and moderation with summary of key points throughout.”

  • Director, Molecular Pathology

“Excellent speakers, panels, participants, and facilitation on relevant topics”

  • CEO, genomics company

“It was a unique and diverse group of stakeholders with (most importantly) time to interact with each other. Key gaps that need to be bridged were openly discussed and at least understood, if not resolved.”

  • Chief Medical Officer

“I thought that the summit raised important issues and brought together interested and diverse individuals to exchange ideas and propose serious solutions to real problems in the field.”

  • President, advocacy organization

“Open discussion, and a focus on actionable takeaways. Attendance by people who are influential.”

  • Director, Science Policy
This event is by invitation only. If you would like to nominate somebody, including yourself, to participate in the summit, please complete the following form: